Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Infectious Diseases and Therapy|July 20, 2016
Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureusJuwon Yim, Jordan R Smith, Katie E Barber, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2016
β-Lactamase Inhibitors Enhance the Synergy between β-Lactam Antibiotics and Daptomycin against Methicillin-Resistant Staphylococcus aureusKarl Evans R Henson, Juwon Yim, Jordan R Smith, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an <i>In Vitro</i> Model of Simulated Endocardial VegetationsJordan R Smith, Juwon Yim, Seth Rice, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant <i>Enterococcus</i> <i>faecium</i> and <i>faecalis</i>Katie E Barber, Zade Shammout, Jordan R Smith, et al.
Infectious Diseases and Therapy|April 8, 2017
Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive InfectionsCassie L Stewart, Michelle S Turner, Jeremy J Frens, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2015
β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faeciumJordan R Smith, Katie E Barber, Animesh Raut, et al.
Diagnostic Microbiology and Infectious Disease|January 23, 2017
Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patientsKenneth Vi Rolston, Weiqun Wang, Lior Nesher, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic ModelKatie E Barber, Jordan R Smith, Cortney E Ireland, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2016
Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro, Hollow-Fiber ModelJordan R Smith, Anu Arya, Juwon Yim, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2018
Evaluation of dalbavancin alone and in combination with β-lactam antibiotics against resistant phenotypes of Staphylococcus aureusXhilda Xhemali, Jordan R Smith, Razieh Kebriaei, et al.
Pageof 3